X-152728200-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001102576.3(CSAG1):c.41T>C(p.Leu14Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001102576.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSAG1 | NM_001102576.3 | c.41T>C | p.Leu14Pro | missense_variant | Exon 3 of 4 | ENST00000452779.3 | NP_001096046.2 | |
CSAG1 | NM_153478.3 | c.41T>C | p.Leu14Pro | missense_variant | Exon 4 of 5 | NP_705611.2 | ||
CSAG1 | XM_047441858.1 | c.41T>C | p.Leu14Pro | missense_variant | Exon 3 of 4 | XP_047297814.1 | ||
CSAG1 | XM_047441859.1 | c.41T>C | p.Leu14Pro | missense_variant | Exon 3 of 4 | XP_047297815.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSAG1 | ENST00000452779.3 | c.41T>C | p.Leu14Pro | missense_variant | Exon 3 of 4 | 1 | NM_001102576.3 | ENSP00000396520.2 | ||
CSAG1 | ENST00000370287.7 | c.41T>C | p.Leu14Pro | missense_variant | Exon 4 of 5 | 1 | ENSP00000359310.3 | |||
CSAG1 | ENST00000370291.6 | c.41T>C | p.Leu14Pro | missense_variant | Exon 4 of 4 | 1 | ENSP00000359314.2 | |||
CSAG1 | ENST00000361211.9 | n.48T>C | non_coding_transcript_exon_variant | Exon 3 of 4 | 1 | ENSP00000354898.5 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.41T>C (p.L14P) alteration is located in exon 4 (coding exon 2) of the CSAG1 gene. This alteration results from a T to C substitution at nucleotide position 41, causing the leucine (L) at amino acid position 14 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.